Dr. Kathrin Brenker
(Founder and CEO of opto biolabs)
“During my PhD with Prof. Michael Reth at the University of Freiburg, I used the optogenetic protein Dronpa to regulate B lymphocyte activity. At the time being the only person in our lab working with optogenetics, we had zero established methods to analyse our cellular systems. After spending weeks in the dark room at the microscope I was majorly frustrated by the small number of cells one can analyze at once. This led me to develop an illumination device that combines optogentics with flow cytometry, enabling the analysis of 30.000 cells/second (Brenker et al., 2016, JoVE) “